- Home
- DOYU vs JUNS Comparison
DOYU vs JUNS Comparison
Compare DOYU & JUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOYU
- JUNS
- Stock Information
- Founded
- DOYU 2014
- JUNS 2015
- Country
- DOYU China
- JUNS United States
- Employees
- DOYU N/A
- JUNS N/A
- Industry
- DOYU Computer Software: Programming Data Processing
- JUNS
- Sector
- DOYU Technology
- JUNS
- Exchange
- DOYU Nasdaq
- JUNS NYSE
- Market Cap
- DOYU 278.1M
- JUNS 281.4M
- IPO Year
- DOYU 2019
- JUNS 2024
- Fundamental
- Price
- DOYU $7.58
- JUNS $0.70
- Analyst Decision
- DOYU Sell
- JUNS
- Analyst Count
- DOYU 3
- JUNS 0
- Target Price
- DOYU $10.33
- JUNS N/A
- AVG Volume (30 Days)
- DOYU 279.2K
- JUNS 127.7K
- Earning Date
- DOYU 03-14-2025
- JUNS 05-11-2025
- Dividend Yield
- DOYU 518.47%
- JUNS N/A
- EPS Growth
- DOYU N/A
- JUNS N/A
- EPS
- DOYU N/A
- JUNS N/A
- Revenue
- DOYU $585,116,657.00
- JUNS N/A
- Revenue This Year
- DOYU N/A
- JUNS N/A
- Revenue Next Year
- DOYU $3.83
- JUNS N/A
- P/E Ratio
- DOYU N/A
- JUNS N/A
- Revenue Growth
- DOYU N/A
- JUNS N/A
- 52 Week Low
- DOYU $6.45
- JUNS $0.55
- 52 Week High
- DOYU $20.17
- JUNS $19.51
- Technical
- Relative Strength Index (RSI)
- DOYU 37.26
- JUNS N/A
- Support Level
- DOYU $7.50
- JUNS N/A
- Resistance Level
- DOYU $8.22
- JUNS N/A
- Average True Range (ATR)
- DOYU 0.77
- JUNS 0.00
- MACD
- DOYU 0.18
- JUNS 0.00
- Stochastic Oscillator
- DOYU 5.24
- JUNS 0.00
About DOYU DouYu International Holdings Limited ADS
DouYu International Holdings Ltd is a game-centric live streaming platform in China and a pioneer in the eSports value chain. The company operates its platform on both PC and mobile apps, through which users can enjoy immersive and interactive games and entertainment live streaming. It generates revenues through live streaming and advertisement.
About JUNS JUPITER NEUROSCIENCES INC
Jupiter Neurosciences Inc is a clinical stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a unique resveratrol platform product primarily targeting treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to most central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.